Your session is about to expire
← Back to Search
Opioid Partial Agonist
Telehealth Intervention for Opioid Overdose (BBB Trial)
N/A
Recruiting
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1,2,4,8,and 12 weeks
Awards & highlights
BBB Trial Summary
This trial will test if telemedicine intervention delivered through public libraries can help reduce opioid overdoses among unstably housed individuals.
Who is the study for?
This trial is for individuals seeking treatment for opioid use disorder (OUD), regardless of their OUD and treatment history. It's open to library patrons who are not currently on buprenorphine with an active medical prescriber, or those who need a new provider. Accommodations will be made for participants with disabilities.Check my eligibility
What is being tested?
The 'Bupe by the Book' study tests if using telehealth in public libraries can improve access to buprenorphine treatment for unstably housed individuals. Participants will be randomly assigned to either weekly telehealth sessions at the library or standard in-person clinic visits over a period of 12 weeks.See study design
What are the potential side effects?
While specific side effects are not listed, buprenorphine may commonly cause symptoms like nausea, drowsiness, constipation, headache, or sweating. Side effects vary from person to person.
BBB Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1,2,4,8,and 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1,2,4,8,and 12 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
buprenorphine adherence
buprenorphine uptake
Secondary outcome measures
Opioid use/overdose and other substance use
adherence to appointments
telebupe feasibility
BBB Trial Design
2Treatment groups
Experimental Treatment
Group I: Treatment as UsualExperimental Treatment2 Interventions
Treatment as usual (in-person at clinic)
Group II: TelehealthExperimental Treatment1 Intervention
Intervention arm
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Control group
2020
N/A
~1870
Find a Location
Who is running the clinical trial?
University of California, San DiegoLead Sponsor
1,122 Previous Clinical Trials
1,520,984 Total Patients Enrolled
San Diego State UniversityOTHER
153 Previous Clinical Trials
84,273 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am not currently on buprenorphine with an active prescription, or I cannot continue with my current provider.I am interested in treatment for opioid use disorder.I have a disability and require accommodations.My doctor agrees that bupe is right for me and I can join the BBB program.
Research Study Groups:
This trial has the following groups:- Group 1: Telehealth
- Group 2: Treatment as Usual
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are recruitment efforts currently underway for this medical experiment?
"Based on the information available, this clinical trial is not currently accepting new participants. Initially posted in May 1st of 2023 and last modified two weeks later, patients are barred from joining; however, there are other trials that remain open to enrolment at present."
Answered by AI
Popular Categories
Share this study with friends
Copy Link
Messenger